February 2022 updates to the website
16 February 2022
The website has now been updated following February's LSCMMG
The following guidelines have been added/updated:
Overactive bladder in female adults - added
The following medicines have been added/updated:
Botulinum Toxin Type A for cosmetic procedures - updated entry with resources
Sacubitril Valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (NICE TA388) - updated entry with supporting information
Sodium Zirconium Cyclosilicate for treating hyperkalaemia (NICE TA599) - updated entry following NICE TA update
The following Items will be updated and added to the website following the next Strategic Commissioning Committee (SCC) Meeting:
Solriamfetol - Treating excessive daytime sleepiness caused by narcolepsy (NICE TA758)